Published in Biotech Business Week, December 20th, 2004
The presentation occurred at the 9th Annual Meeting of the Society for Neuro-Oncology (SNO) in Toronto, Canada.
The oral presentation entitled, "Cumulative Dose of Motexafin Gadolinium (MGd) and Survival in Newly Diagnosed Glioblastoma Multiforme (GBM)," was presented by See-Chun Phan, MD, a medical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.